Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Unknown 5Recruiting 3Completed 3Terminated 2

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Neoplasms 2Breast Neoplasms 2Pancreatic Neoplasms 1Heart Failure 1Cardiotoxicity 1Atherosclerosis 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Clear all
NCT04245644 2024-03-12

CAOS

IRCCS San Raffaele

Unknown
800 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05976893 2023-08-04

Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer

Xinjiang Medical University

Phase 4 Unknown
620 enrolled

Neoplasms, Atherosclerosis

NCT03186404 2022-02-08

SPARE-HF

University Health Network, Toronto

Phase 2 Unknown
112 enrolled

Heart Failure, Neoplasms, Cardiotoxicity

NCT03971019 2019-08-14

SBSBC

Peking Union Medical College Hospital

Phase 3 Unknown
314 enrolled
Breast

Breast Neoplasms

NCT00914017 2010-02-11

Statins and Breast Cancer Biomarkers

University of Vermont

Phase 2 Unknown
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡